Zurueck zur Suche

Reporte zur Charge EL3247 SCH

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
RI 2

VAERS 1405392

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EL3247SCH

mild
Staat
RI
Alter
75,0
Geschlecht
F
Eingang
17.06.2021
Impfdatum
24.02.2021
Beginn
01.03.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash erythematous Rash pruritic

Symptomtext

Raised rash around collarbone neck and back [...] red and itchy; Raised rash around collarbone neck and back [...] red and itchy; This is a spontaneous report from a contactable consumer. A 75-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the right arm, on 24Feb2021 (Batch/Lot Number: EL3247SCH), at the age of 75 years old, as 1st single dose, for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included hydrochlorothiazide, omeprazole, pregabalin (LYRICA), meloxicam, propranolol, loratadine, fluticasone propionate (FLONASE ALLERGY RELIEF), vitamin D, docusate, paracetamol (TYLENOL), and leflunomide. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced raised rash around collarbone neck and back occurring approximately 1 week post vaccination. It was not fluid filled, but red and itchy. She saw her primary care provider (PCP) about 1 week post symptoms (about 2 weeks post vaccination) and was given triamcinolone 0.25% cream as treatment and was told to follow-up with a dermatologist and immunologist. Itching relieved temporarily with cream but the rash was still there at the time of the reporting. Dermatology appointment was scheduled for 19Mar2021. She was scheduled to receive second vaccination dose on the day of this initial reporting. The patient was considered not recovered from the event. Since the vaccination, has the patient had not been tested for COVID-19. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash erythematous
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
HYDROCHLOROTHIAZIDE; OMEPRAZOLE; LYRICA; MELOXICAM; PROPRANOLOL; LORATADINE; FLONASE ALLERGY RELIEF; VITAMIN D [ERGOCALCIFEROL]; DOCUSATE; TYLENOL; LEFLUNOMIDE
Allergien
-
Vorherige Impfungen
-

VAERS 1111911

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EL3247 SCH

mild
Staat
RI
Alter
67,0
Geschlecht
F
Eingang
18.03.2021
Impfdatum
01.03.2021
Beginn
18.03.2021
Tage bis Beginn
17,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Headache Malaise Myalgia Pyrexia

Symptomtext

Fever, headache, weakness, malaise, muscle aches

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
I tested positive for covid on 2/25/2021, 3 days after my first Pfizer shot.
Vorgeschichte
None
Andere Medikamente
Emergency gummies, one a day vitamin
Allergien
None
Vorherige Impfungen
-